Medical Services Advisory Committee - Applications Considered
- 1196.2 - Repetitive Transcranial Magnetic Stimulation (rTMS) for the treatment of depression (resubmission)
- 1342.5 – Oncotype DX breast cancer assay to quantify the risk of disease recurrence and predict adjuvant chemotherapy benefit (resubmission)
- 1435.1 - Processing and cryopreservation of ovarian tissue (resubmission)
- 1476 - Genetic testing for childhood syndromes
- 1510.1 - Emicizumab for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in patients with Haemophilia A (resubmission)
- 1515 - Endoscopic placement and removal of an intra-gastric balloon (IGB) for the management of overweight and obesity in a high-risk patient
- 1519.1 - Tisagenlecleucel (CTL019) for treatment of relapsed or refractory diffuse large B-cell lymphoma (resubmission)
- 1524 - Expanding the BRAF testing MBS item to include patients with resectable Stage III melanoma
- 1525 - Low dose rate (LDR) brachytherapy for intermediate and high-risk prostate cancer
- 1526 - Somatic tumour gene testing for the diagnosis of diffuse large B cell lymphoma, multiple myeloma and non-Hodgkin lymphoma subtypes
- 1527 - Somatic tumour gene testing for the diagnosis of gliomas, gliobastomas, and soft tissue and bone tumours
- 1528 - Somatic tumour gene testing for the diagnosis of renal cell carcinoma, hydatidiform moles, granulosa cell ovarian tumour, salivary gland tumours, and secretory carcinoma of the breast
- 1541 - Micro-bypass glaucoma surgery (MBGS) device implantation as a standalone procedure in patients with open-angle glaucoma (OAG)
- 1579 - Emicizumab for routine prophylaxis to prevent bleeding or reduce the frequency of bleeding episodes in patients with moderate to severe Haemophilia A (congenital Factor VIII deficiency) WITHOUT Factor VIII inhibitors
- 1584 - Radionuclide Imaging for for the diagnosis of transthyretin amyloid cardiomyopathy
- 1589 – Nusinersen as a treatment for presence of motor neurone 2 (SMN2) gene